GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Mitsubishi Chemical Group Corp (OTCPK:MTLHY) » Definitions » 6-1 Month Momentum %

MTLHY (Mitsubishi Chemical Group) 6-1 Month Momentum % : 3.11% (As of Dec. 13, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Mitsubishi Chemical Group 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-12-13), Mitsubishi Chemical Group's 6-1 Month Momentum % is 3.11%.

The industry rank for Mitsubishi Chemical Group's 6-1 Month Momentum % or its related term are showing as below:

MTLHY's 6-1 Month Momentum % is ranked better than
50.1% of 1575 companies
in the Chemicals industry
Industry Median: 1.69 vs MTLHY: 3.11

Competitive Comparison of Mitsubishi Chemical Group's 6-1 Month Momentum %

For the Specialty Chemicals subindustry, Mitsubishi Chemical Group's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mitsubishi Chemical Group's 6-1 Month Momentum % Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Mitsubishi Chemical Group's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Mitsubishi Chemical Group's 6-1 Month Momentum % falls into.



Mitsubishi Chemical Group  (OTCPK:MTLHY) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mitsubishi Chemical Group  (OTCPK:MTLHY) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Mitsubishi Chemical Group 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Mitsubishi Chemical Group's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mitsubishi Chemical Group Business Description

Traded in Other Exchanges
Address
1-1 Marunouchi 1-chome, Chiyoda-ku, Tokyo, JPN, 100-8251
Mitsubishi Chemical Group Corp is a holdings company, which manufactures and sells chemicals, plastics, and pharmaceuticals. It organizes itself into three segments based on product. The Industrial Materials segment, which generates the majority of revenue, sells chemicals and polymers, including industrial gases, petrochemicals, thermoplastics, polyethylene, and polypropylene. The Performance Products segment sells electronics and designed materials, including LED lighting and equipment, specialty chemicals, polyester and industrial films, and fibers. The Health Care segment sells pharmaceuticals to treat autoimmune diseases, diabetes and kidney diseases, central nervous system treatments, and vaccines. The majority of revenue comes from Japan.